Abstract
Serotonergic axons from the raphe nuclei in the brainstem project to every region of the brain, where they make connections through their extensive terminal arborizations. This serotonergic innervation contributes to various normal behaviors and psychiatric disorders. The protocadherin-α (Pcdha) family of clustered protocadherins consists of 14 cadherin-related molecules generated from a single gene cluster. We found that the Pcdhas were strongly expressed in the serotonergic neurons. To elucidate their roles, we examined serotonergic fibers in a mouse mutant (PcdhaΔCR/ΔCR) lacking the Pcdha cytoplasmic region-encoding exons, which are common to the gene cluster. In the first week after birth, the distribution pattern of serotonergic fibers in PcdhaΔCR/ΔCR mice was similar to wild-type, but by 3 weeks of age, when the serotonergic axonal termini complete their arborizations, the distribution of the projections was abnormal. In some target regions, notably the globus pallidus and substantia nigra, the normally even distribution of serotonin axonal terminals was, in the mutants, dense at the periphery of each region, but sparse in the center. In the stratum lacunosum-moleculare of the hippocampus, the mutants showed denser serotonergic innervation than in wild-type, and in the dentate gyrus of the hippocampus and the caudate-putamen, the innervation was sparser. Together, the abnormalities suggested that Pcdha proteins are important in the late-stage maturation of serotonergic projections. Further examination of alternatively spliced exons encoding the cytoplasmic tail showed that the A-type (but not the B-type) cytoplasmic tail was essential for the normal development of serotonergic projections.
Introduction
The largest family in the cadherin superfamily is the clustered protocadherins, which are mainly expressed in neurons and localized to axons and synapses (Obata et al., 1995; Kohmura et al., 1998; Phillips et al., 2003; Junghans et al., 2008; Yagi, 2008). All the clustered protocadherin genes encode type I transmembrane proteins with six extracellular cadherin domains (Wu and Maniatis, 1999). The murine clustered protocadherins are further classified into three subfamilies, according to their position within the gene cluster: protocadherin-α (Pcdha, 14 genes), protocadherin-β (Pcdhb, 22 genes), and protocadherin-γ (Pcdhg, 22 genes) (Sugino et al., 2000; Wu et al., 2001). Interestingly, only a few, randomly selected genes of the Pcdha and Pcdhg clusters are expressed in individual Purkinje cells (Esumi et al., 2005; Kaneko et al., 2006). Thus, a given neuron expresses a diverse combination of individual clustered protocadherin molecules, consistent with the idea that differential expression of these genes may confer a unique identity on each neuron.
In humans, these clustered Pcdh genes are located on chromosome 5q31, a candidate locus for schizophrenia (SZ)- and bipolar disorder (BD)-related pathogenesis (Schwab et al., 1997; Lewis et al., 2003). Recently, a single nucleotide polymorphism (SNP) in the Pcdha gene locus was significantly linked to BD (Pedrosa et al., 2008). In addition, we recently reported that hypomorphic Pcdha mutant mice exhibit enhanced contextual fear conditioning and abnormal spatial learning (Fukuda et al., 2008). All of these findings are consistent with the 5q31-linked Pcdh locus being a disease-susceptibility locus for certain psychiatric disorders.
Our current focus is on defining the brain regions in which the Pcdha genes are strongly expressed, and elucidating their roles in these regions. In a study of the olfactory sensory neurons (OSNs), which strongly express the Pcdha proteins, we found abnormal, ectopic olfactory neuronal projections in a Pcdha mutant (PcdhaΔCR/ΔCR) mouse, which lacks the constant region (CR) exons encoding the common cytoplasmic tails of all Pcdha proteins (Hasegawa et al., 2008).
Here we focused on Pcdh expression in serotonergic neurons, and found by in situ hybridization analysis that Pcdha, but not Pcdhg, is strongly expressed in the serotonergic neurons of the rostral raphe nuclei from fetal stages to adulthood. We examined the projections of the serotonergic neurons in the PcdhaΔCR/ΔCR mice, because we had found abnormal projections in the mutant OSN axons (Hasegawa et al., 2008). In wild-type (WT) mice, serotonergic axons project to target regions throughout the brain; however, in the PcdhaΔCR/ΔCR mice, these projections were incomplete with immature arborizations. Given the effect of the mutant cytoplasmic tail, we also tested the A and B isotypes of this region. Mice lacking the Pcdha A-type domain (PcdhaΔA/ΔA), but not those lacking the Pcdha B-type domain (PcdhaΔB/ΔB), showed much the same serotonergic fiber phenotypes as PcdhaΔCR/ΔCR mice. Our data suggested that the Pcdha family plays essential roles in the maturation of serotonergic projections in the brain, and that the Pcdha A-type cytoplasmic tail is specifically important in this process.
Materials and Methods
Animal experiments.
All the experimental procedures were in accordance with the Guide for the Care and Use of Laboratory Animals of the Science Council of Japan and were approved by the Animal Experiment Committee of Osaka University.
In situ hybridization histochemistry.
We performed in situ hybridization histochemistry, as described previously with small modifications (Schaeren-Wiemers and Gerfin-Moser, 1993). To detect all of Pcdha transcripts (GenBank accession number D86916, nucleotides 2518–4559), all the Pcdhg transcripts (GenBank accession number NM033584, nucleotides 2485–4383), and the serotonin transporter (SERT) transcript (GenBank accession number NM_010484, nucleotides 235–1733), Pcdha-CR, Pcdhg-CR and SERT cRNA probes were synthesized using a digoxigenin-UTP RNA labeling Kit (Roche) according to the manufacturer's instructions. Mice were deeply anesthetized with diethyl ether, then the brain was removed, embedded in O.C.T. compound (Sakura), and quickly frozen in isopentane cooled with dry ice. Sections (10-μm-thick) were cut on a cryostat (Leica CM3050), thaw-mounted on slides (Matsunami), and air-dried. The sections were fixed in 4% paraformaldehyde (PFA) in 0.1m phosphate buffer (PB, pH 7.3) for 10 min, washed three times in PBS, pH 7.4, acetylated for 10 min in 0.25% acetic anhydride in 0.1 m triethanolamine-HCl, pH 8.0, and washed three more times with PBS. Prehybridization was performed with hybridization buffer [50% formamide, 5× SSC (20× SSC is 3 m NaCl, 0.3 m sodium citrate, pH 7.0), 5× Denhardt's, 250 μg/ml yeast tRNA, 500 μg/ml salmon sperm DNA, and 0.2% protectRNA RNase inhibitor (Sigma)] for 30 min. The digoxigenin-labeled cRNA probes were denatured for 5 min at 82°C and chilled on ice. Hybridization buffer containing 1 μg/ml of the cRNA probes was dropped onto the sections, and a coverslip was added. The slides were incubated for 12 h at 72°C in a humidified chamber (50% formaldehyde, 5× SSC), washed four times with 0.2× SSC at 72°C, washed three times with TBS, pH 7.5 (100 mm Tris-HCl, pH 7.5, 100 mm NaCl), and rinsed with TNT (0.05% Tween 20 in TBS, pH 7.5). To detect the hybridized probes, the sections were blocked with blocking solution (2.5% skim milk in TNT) for 30 min, and then incubated with alkaline phosphatase (AP)-conjugated anti-digoxigenin antibody (1:1000 dilution, Roche) in the blocking solution for 1 h. The sections were rinsed three times with TBS, pH 7.5, and the enzymatic activity was visualized with 0.2 mm 5-bromo-4-chloro-3-indolyl-phosphate, 0.2 mm nitro blue tetrazolium in 100 mm Tris-HCl, pH 9.5, 100 mm NaCl, 20 mm MgCl2, in the dark, until the signal reached a satisfactory intensity.
We also carried double fluorescent in situ hybridization. A fluorescein-labeled SERT cRNA probe was synthesized with a fluoresein-UTP RNA labeling Kit (Roche). Both digoxigenin-labeled Pcdha-CR and fluorescein-labeled SERT cRNA probes were hybridized to sections, and washed (see above). After rinsed with TNT, the sections were blocked with the blocking solution, and then incubated with anti-digoxigenin peroxidase (POD)-labeled anti-digoxigenin Fab fragments (1:3000 dilution; Roche) in the blocking solution for 3 h, and washed three times with TNT. The signal of Pcdha transcript was amplified and detected by TSA Plus Cyanine 3 system (PerkinElmer). The sections were washed three times with TNT, and rinsed with TBS, pH 7.5. For the inactivation of the POD, the sections were incubated in 2% H2O2 in TBS, pH 7.5 for 15 min twice, and washed with TBS, pH 7.5 three times. The sections were incubated with POD-labeled anti-digoxigenin Fab fragments (1:3000 dilution, Roche) in the blocking solution for 3 h, and washed with TNT three times, and washed with TBS, pH 7.5. The signal of SERT transcript was amplified by TSA Plus DNP (HRP) System (Perkin-Elmer), and washed with TNT three times. The sections were incubated with anti-dinitrophenyl (DNP)-Alexa 488 (1:1000 dilution, Invitrogen) in the blocking solution for 1 h, washed with TNT three times and the signal of SERT transcript was detected.
Generation of Pcdha mutant mice.
The CR exons of the Pcdha gene cluster generate two alternative carboxy-terminal regions: A and B (see Fig. 2A,B). The type A-deleted (ΔAneo), type B-deleted (ΔB) (see Fig. 2E) and CR-deleted (ΔCR) (see Fig. 2C) alleles were produced as described previously (Fukuda et al., 2008; Hasegawa et al., 2008). Since PcdhaΔAneo/ΔAneo brains express considerably smaller amount of truncated Pcdha proteins probably because of promoter interference of PGK-neo, we generated a new genetically modified allele, ΔA allele, in which a floxed PGK-neo in ΔAneo allele was removed by crossing the Pcdha+/ΔAneo mice with a line expressing Cre recombinase under the control of the CAG promoter (CAG-Cre) (Kawamoto et al., 2000) (supplemental Fig. 1A, available at www.jneurosci.org as supplemental material). The genotypes of the Pcdha+/ΔA and PcdhaΔA/ΔA mice were confirmed by PCR using primers NA-F (5′-GGTGAGTTGCCAGACAAATTC-3′) and mh1–2R (5′-GCCCTGCAAATATCATCAAT-3′) (supplemental Fig. 1B, available at www.jneurosci.org as supplemental material). All of the gene-targeted mice used in this study were backcrossed to C57BL/6 mice >8 times.
Immunohistochemistry.
Male mice were deeply anesthetized with diethyl ether and perfused transcardially with PBS followed by 4% PFA in 0.1 m PB. After perfusion fixation, the brain was rapidly removed and immersed in the same fixative for 8 h. The brain was then immersed in 20% sucrose in 0.1 m PB overnight and frozen in O.C.T. compound with isopentane cooled by dry ice. Coronal and sagittal sections were cut on a cryostat, thaw-mounted on slides, and air-dried as described above. The sections were washed with PBS, blocked for 1 h with PBST (0.2% Triton X-100 in PBS) containing 20% blocking reagent and 5% normal goat serum, and incubated with a rabbit polyclonal anti-SERT antibody (HTT-N77, a generous gift from Dr. Masahiko Watanabe, Hokkaido University, Japan) in PBST containing 5% blocking reagent for 12 h at 4°C. The sections were rinsed with PBST and incubated with biotinylated anti-rabbit IgG antibody (1:500 dilution; Vector Laboratories) in PBST containing 5% blocking reagent for 2 h. The sections were washed with PBS, incubated with avidin-biotin complex (1:100 dilution; Vector Laboratories) in PBS for 1 h, and washed again with PBS. Finally, the sections were rinsed with 0.02% diaminobenzidine tetrachloride (DAB) in PBS, and reacted with 0.02% DAB and 0.002% H2O2 in PBS for 5–8 min.
Cytochrome oxidase histochemistry.
Mice were deeply anesthetized with diethyl ether and perfused with PBS followed by 4% PFA in 0.1 m PB. After the perfusion, cerebral hemispheres were removed, flattened between two glass slides, and then immersed the same fixative for 2 h. The flattened tissues were immersed in 0.1 m PB containing 25% sucrose overnight for cryoprotection. Sections (50 μm) were cut on a freezing microtome and were rinsed with 0.1 m PB. The cytochrome oxidase activity was visualized with the solution containing 0.05% cytochrome C, 0.05% DAB and 4% sucrose for 1 h at 37°C. The sections were then rinsed with 0.1 m PB and mounted onto glass slides and enclosed in 0.05 m PB containing 50% glycerol.
Illustrations and analysis of serotonergic fiber distribution and morphology.
Sections stained by in situ hybridization histochemistry and immunohistochemistry were examined with an Olympus microscope (BX51), and photographed with a CCD camera (Olympus DP-50). The brightness and contrast were adjusted in Adobe Photoshop (Adobe Systems). To improve the visibility of the SERT-immunopositive (i.p.) fibers, the absolute values of the difference between the 8-bit color tissue images and their nontissue background images were mathematically calculated with Photoshop. The background-removed images were converted to 8-bit grayscale images. To extract SERT-i.p. fibers specifically, we converted the grayscale images to binary images by setting a threshold for a brightness value. The density of SERT-i.p. fibers in the dorsal parts of the hippocampus in three parasagittal sections (0.7, 0.8, and 0.9 mm from the midsagittal plane) was automatically measured in the region of interest (see Fig. 5E) per animal by NIH ImageJ 1.36b.
Quantification of SERT-positive cells.
Serial sagittal sections (10 μm thick) were prepared from male mouse brains at postnatal day (P) 21 (n = 4 WT; n = 4 PcdhaΔCR/ΔCR). Semiserial sections (one of each set of four) were hybridized with the SERT cRNA probe, and signals were detected by in situ hybridization histochemistry. In the rostral raphe nuclei from the midline (0 μm) and laterally (bilateral; 720 μm from the midline), only SERT transcript-positive cells whose nucleus could be discriminated were counted.
Statistical analysis.
We used StatView software (SAS Institute) for statistical analyses. Statistical analyses between multiple mouse lines were done with one-factor ANOVA and Scheffé's F test. Statistical analyses between two mouse lines were done with the Mann–Whitney U test. Overall survivals of WT and mutant mice were examined with the Kaplan–Meier methods, and differences were done with logrank test. Values in graphs are expressed as the mean ± SD.
Production of Pcdha-CR monoclonal antibodies.
To generate specific monoclonal antibodies against all Pcdha proteins and a Pcdhac2 protein, we used amino acid sequences of the CR that is common to both the A- and B-types (PcdhaAB) and the specific extracellular domain of the Pcdhac2 (Pcdhac2EC2–3), respectively. The regions were amplified with primer pairs (5′-CCCCGGCAGCCCAACCCT-3′ and 5′-GGGACCGGACTGTTTGGG-3′ for PcdhaAB) or (5′-CCGGAATTCCCGCGGCCGGATTATCAGCTT-3′ and 5′-CCGCTCGAGCACCTCTGGAGCGTTGTCATT-3′ for Pcdhac2EC2-3) and cloned into the BamHI and EcoRI sites, or the EcoRI and XhoI sites of pGEX6P-1 (GE Healthcare), and the vectors were introduced into Escherichia coli (DH5α). The glutathione S-transferase (GST)-PcdhaAB fusion protein and the GST-Pcdhac2EC2–3 fusion protein were extracted from the E. coli by a Glutathione Sepharose 4 Fast Flow (GE Healthcare) column, and the PcdhaAB protein were obtained by cleavage with PreScission Protease (GE Healthcare). Emulsions of the PcdhaAB and GST-Pcdhac2EC2-3 proteins by TiterMAX GOLD adjuvant (CytRx Corporation) were injected four times intraperitoneally into PcdhaΔCR/ΔCR female mice (Hasegawa et al., 2008) and Pcdhadel(11−c2)/del(11−c2) female mice, in which Pcdha11–Pcdhac2 genes were deleted (Noguchi Y, Hirabayashi T, Katori S, Kawamura Y, Sanbo M, Hirabayashi M, Kiyonari H, Nakao K, Uchimura A, Yagi T, unpublished data), respectively. After the one or three booster immunizations, the spleens were extirpated and dispersed by passing it through a mesh (stainless steel, pore size: 100 μm). The spleen cells were fused with P3UI mouse myeloma cells at a 5:1 ratio by polyethylene glycol. The fused cells were plated in ClonaCell-HY (StemCell Technologies). After 10 d, the colonies were individually collected into 96-well plates and cultured in 10% fetal bovine serum-10% BM Condimed (Roche)-RPMI medium (FBRM) containing hypoxanthine and thymidine. Immunopositive supernatant against the PcdhaAB and Pcdhac2EC2-3 protein was screened with ELISA and immunoblotting, and positive colonies were selected. Hybridomas (colony name: 4F8) producing an antibody against the PcdhaAB protein were injected into nude mice, and their ascitic fluid was used as an anti-Pcdha-CR antibody. Hybridomas (colony name: 8B6) producing an antibody against the Pcdhac2EC2-3 protein were cultured in FBRM, and the supernatant was used as an anti-Pcdha-c2 antibody. The specificity of these antibodies was confirmed with immunoblotting for brain lysate.
Immunoblotting.
Whole P21 brains were dissected and homogenized in 50 mm Tris-HCl, pH 7.5, 2 mm EDTA, 2% SDS, 10 μg/ml pepstatin, and 10 μg/ml leupeptin. The homogenate was spun at 20,000 × g at 4°C for 30 min. An equal volume of SDS sample buffer (60 mm Tris-HCl, pH 6.7, 2% v/v 2-mercaptoethanol, and 5% glycerol) was added to the lysates for SDS-PAGE followed by immunoblotting. The anti-Pcdha-CR and Pcdha-c2 (8B6) antibodies were used at 1:100 and 1:2 dilutions, respectively.
Reverse transcription-PCR.
Total RNAs from mouse whole brains at P21 were extracted with TRIzol reagent (Invitrogen), and cDNAs were synthesized from the total RNAs with oligo-dT primers and Superscript III (Invitrogen) reverse transcriptase, following the manufacturer's protocol. To detect Pcdha A-type and B-type transcripts, the cDNAs were amplified by PCR with forward primer CP1-F4 (5′-CGCTACTCTGCCTCGCTAA-3′) and reverse primer CP3-R2 (5′-TGCAATCCTGCAGAGCTGAAG-3′).
Measurement of monoamines by high performance liquid chromatography (HPLC).
The amounts of monoamines and their metabolites were measured using HPLC with electrochemical detection (described by Fukuda et al., 2008). Mice were killed by decapitation at 10 weeks of age, and the brain regions were rapidly dissected out and frozen at −80°C, until assayed. Each sample of frozen brain tissue was homogenized by ultrasonic irradiation in 250 μl of 0.2 m perchloric acid containing isoproterenol as an internal standard. The homogenates were placed on ice for 30 min and spun at 20,000 × g for 15 min at 4°C. The supernatants were filtered through a syringe filter unit (DISMIC-3; Advantec), their pH was adjusted to 3.0 with 1 m sodium acetate, and they were then injected into an HPLC system equipped with an ODS column (Eicompak SC3-ODS; 3 × 100 mm; Eicom) and an electrochemical detector (EDC-100; Eicom) with the potential set at +750 mV. The mobile phase was 0.1 m citric acid and 0.1 m sodium acetate, pH 3.5, containing sodium-1-octansulfonate (190 mg/L), EDTA-2Na (5 mg/L), and 17% methanol. The flow rate was set at 0.25 ml/min. The protein content was measured using the Bradford protein assay solution (Bio-Rad) after the precipitates were solubilized with 0.1 m NaOH.
Results
Serotonergic neurons intensely express Pcdhas in the mouse brain
To investigate where Pcdha transcripts are most strongly expressed in the brain, we examined the expression pattern of Pcdha transcripts by in situ hybridization histochemistry, using a Pcdha-CR cRNA probe to detect all the Pcdha transcripts (Esumi et al., 2005; Hasegawa et al., 2008). As has been reported, strong signals for Pcdha were detected in the olfactory bulb, neocortex, hippocampus, and cerebellum (in the Purkinje cells) (Fig. 1A) (Carroll et al., 2001; Morishita et al., 2004; Esumi et al., 2005; Hasegawa et al., 2008). In addition to these regions, we found that the rostral raphe nuclei were among the strongest expressors of Pcdha in the brain (Fig. 1A), with a peak between (E) 14.5 and P14 (Fig. 1C–F), and expression was maintained through adulthood (Fig. 1G). Serotonergic neurons in the raphe nuclei specifically express SERT. The cells of the rostral raphe nuclei that were positive for Pcdha transcript also stained positive for SERT transcript on the same section (Fig. 1H–J), indicating that the serotonergic neurons of the rostral raphe nuclei specifically expressed high levels of Pcdha transcripts.
Since some Pcdha proteins form a molecular complex with Pcdhg proteins (Murata et al., 2004), we compared the overall expression pattern of the Pcdha transcripts with that of Pcdhg. As with Pcdha, we used a CR probe, Pcdhg-CR cRNA, to detect all of the Pcdhg transcripts. Although many brain regions that strongly expressed Pcdha transcripts also showed intense signals for Pcdhg (Fig. 1A, B), the rostral raphe nuclei showed much weaker Pcdhg signals. Thus, serotonin neurons in the raphe nuclei predominantly expressed Pcdha transcripts. We therefore examined the serotonergic system of the Pcdha mutant mouse brain in detail.
Distribution of serotonergic fibers and somata in PcdhaΔCR/ΔCR mice at P21
Recently, we demonstrated that the axonal projections of the OSNs to the olfactory glomeruli are disturbed in PcdhaΔCR/ΔCR mice, which lack the CR exons of Pcdha (Fig. 2C). In PcdhaΔCR/ΔCR brain lysates, Pcdha proteins were not detected by an anti-Pcdha-CR antibody against the common amino acids of the A and B CR types (Fig. 2F), but CR-deleted Pcdha proteins were faintly detected by an anti-Pcdha-c2 antibody against the extracellular region of Pcdha-c2 (Fig. 2G). Therefore, we began our loss-of-function analyses of Pcdha in serotonergic neurons using the PcdhaΔCR/ΔCR mice. To identify the serotonergic fibers, we immunolabeled brain sections with an anti-SERT antibody. There were no obvious cytoarchitectural abnormalities in the regions we examined (data not shown).
Olfactory bulb
In the olfactory bulb, the serotonergic fibers of WT mice were abundant in all layers of the bulb; in comparison, in the PcdhaΔCR/ΔCR mice, there were fewer serotonergic fibers in the layers encompassed by and including the external and internal plexiform layers, and there were more than normal in the granule cell layer (Fig. 3A,B).
Cerebral cortex
In the cingulate cortex (the medial part of the prefrontal cortex), the density of the serotonergic fibers in the PcdhaΔCR/ΔCR mice was lower throughout, compared with WT mice (Fig. 3C,D). In the rostral region of the primary motor cortex, the serotonergic fibers of WT mice were abundant from layers I to VI (Fig. 3E), with a slightly higher density in layers I and IV (Fig. 3E). In contrast, in the PcdhaΔCR/ΔCR mice, layer I was more densely innervated by serotonergic fibers (Fig. 3E,F), and short, clumped fibers were frequently observed in layer II/III of only the most rostral part of the PcdhaΔCR/ΔCR primary motor cortex (Fig. 3F, arrowheads, bottom). In the entorhinal cortex, the density of the serotonergic fibers in the PcdhaΔCR/ΔCR mice was dramatically greater than in WT mice (Fig. 3G,H).
Basal ganglia
In WT mice, the density of serotonergic fibers was moderate at P21 in the caudate-putamen and high in the globus pallidus (Fig. 4A). In PcdhaΔCR/ΔCR mice, the density of serotonergic fibers dramatically decreased in the caudate-putamen and increased in the globus pallidus, compared with WT mice (Fig. 4A,B). Interestingly, the increase of serotonergic fibers in the PcdhaΔCR/ΔCR globus pallidus was prominent only in the peripheral region (Fig. 4B, arrows). Similarly, the density of serotonergic fibers in the PcdhaΔCR/ΔCR mice obviously increased in the peripheral region of the substantia nigra (Fig. 4C,D). In contrast to the peripheral regions, the central regions of the globus pallidus and substantia nigra of the PcdhaΔCR/ΔCR mice were more sparsely innervated by serotonergic fibers compared with WT (Fig. 4B,D, asterisks).
Thalamus
In WT mice serotonergic fibers were distributed almost uniformly in the dorsal lateral geniculate nucleus and medial geniculate nucleus at P21 (Figs. 3G, 4E), whereas in the PcdhaΔCR/ΔCR mice serotonergic fibers were accumulated around these nuclei and sparse in the central regions of these nuclei (Figs. 3H, 4F).
Hippocampus
In WT mice, serotonergic fibers were found throughout the hippocampal region. As has been reported (Lidov et al., 1980; Lidov and Molliver, 1982), the density of the serotonergic fibers in the WT hippocampus was relatively higher in the stratum lacunosum-moleculare and stratum radiatum, and relatively lower in the stratum oriens and dentate gyrus (Fig. 5A,C). In comparison, in the PcdhaΔCR/ΔCR mice, the density of the serotonergic fibers was dramatically increased in the stratum lacunosum-moleculare (Fig. 5B,D). A quantitative analysis revealed that the densities of the serotonergic fibers in the stratum lacunosum-moleculare and the stratum radiatum of CA1 region of PcdhaΔCR/ΔCR mice compared with WT were 184% and 134%, respectively (Fig. 5F). In contrast, in the stratum oriens and dentate gyrus of the PcdhaΔCR/ΔCR hippocampus, the densities were 44% and 21%, respectively, of those levels in WT mice (Fig. 5F). There was no apparent difference in serotonergic fiber density between WT and Pcdha+/ΔCR mice (Fig. 5F), nor was there a significant difference in the average density of the serotonergic fibers as a whole between the WT and PcdhaΔCR/ΔCR mice (Fig. 5F). These results suggest that the distribution pattern, but not total number, of serotonergic fibers in the hippocampus was changed in the mutants.
Serotonergic somata in the rostral raphe nuclei
It was possible that the altered distribution of serotonergic fibers in the brain of PcdhaΔCR/ΔCR mice originated from changes in the distribution and/or number of serotonergic neurons in the rostral raphe nuclei. To investigate this possibility, we examined the brain stem of WT and PcdhaΔCR/ΔCR mice by in situ hybridization histochemistry for SERT transcript. We did not find any apparent difference in the distribution of the serotonergic somata in the rostral raphe nuclei between WT and PcdhaΔCR/ΔCR mice (supplemental Fig. 2A–C, available at www.jneurosci.org as supplemental material), and the number of SERT transcript-positive cells in these nuclei was unchanged (supplemental Fig. 2D, available at www.jneurosci.org as supplemental material).
Serotonergic fibers in the developing brain of PcdhaΔCR/ΔCR mice
To understand how the abnormalities in the serotonergic projections developed in the PcdhaΔCR/ΔCR mice, we examined their distribution pattern in the developing brain.
We first examined serotonergic fibers in the developing basal ganglia of WT and PcdhaΔCR/ΔCR mice. At early postnatal stages (P7), WT serotonergic fibers were sparse in the caudate-putamen and globus pallidus (Fig. 6A), but some concentration was seen at the border between the two regions (Fig. 6A, arrows), and these findings were similar for the PcdhaΔCR/ΔCR mice (Fig. 6B). At P21, the WT serotonergic fibers were fairly evenly distributed in the globus pallidus (Fig. 4A), whereas the PcdhaΔCR/ΔCR serotonergic fibers were concentrated in the peripheral region and sparse in the central region (Fig. 4B). In the substantia nigra and geniculate nuclei, the serotonergic fibers of WT mice at P7 were sparse in the central regions and concentrated in the peripheral regions (Fig. 6C,E), and their distribution was similar to that in the PcdhaΔCR/ΔCR mice (Fig. 6D,F). At P21, WT serotonergic fibers were distributed throughout the substantia nigra and geniculate nuclei (Fig. 4C,E), whereas PcdhaΔCR/ΔCR serotonergic fibers were concentrated in the peripheral regions and sparse in the central regions (Fig. 4D,F), as at P7 (although the innervation was denser) (Fig. 6D). These results show serotonergic fibers of PcdhaΔCR/ΔCR mice concentrating at the periphery of their target region, but barely innervating the interior of the target.
Next, we examined the distribution pattern of serotonergic axons in the developing hippocampus. In P0 WT mice, we detected serotonergic fibers in the stratum radiatum and stratum lacunosum-moleculare (Fig. 6G). At this developmental stage, the border between the stratum radiatum and the stratum lacunosum-moleculare was not well defined. There were also sparse serotonergic fibers in the stratum oriens of P0 WT mice (Fig. 6G), and only a few were detected in the dentate gyrus. The density of serotonergic fibers in the P0 PcdhaΔCR/ΔCR mice (Fig. 6G) was slightly higher than in WT mice (Fig. 6H), but their distribution patterns were essentially the same. At P21, the WT serotonergic fibers were widely distributed in the hippocampus (Fig. 5A), whereas those of the PcdhaΔCR/ΔCR mice were concentrated in the stratum lacunosum-moleculare and remained very sparse in the dentate gyrus (Fig. 5B), as described above. Thus, we concluded that in the PcdhaΔCR/ΔCR mice, the serotonergic projections to their final target regions were incomplete, and apparently lacked their arborization.
Generation of mutant mice in which the Pcdha A-type cytoplasmic tail is deleted
To determine how the CR deletions affected serotonergic target innervation, we investigated the potential roles of the two alternatively spliced A-type and B-type CRs that respectively encode the A-type and B-type cytoplasmic tail. We examined the distribution of serotonergic fibers in two types of Pcdha gene-targeted mice; PcdhaΔA/ΔA and PcdhaΔB/ΔB mice (Fig. 2D,E). In PcdhaΔB/ΔB mice, B-type Pcdha transcripts and proteins were not detectable whereas A-type Pcdha proteins were at normal (Fukuda et al., 2008). On the other hand, PcdhaΔA/ΔA mice should produce truncated A-type Pcdha proteins that lack the A-type specific C-terminal region. We confirmed this truncated protein by immunoblotting with anti-Pcdha-CR and anti-Pcdha-c2 antibodies (Fig. 2F,G). However, and unexpectedly, PcdhaΔA/ΔA mice did not produce B-type Pcdha transcripts, probably because of the loxP insertion near the splice donor site (Fig. 2G,H). Therefore, PcdhaΔA/ΔA mice expressed only truncated Pcdha proteins that lacked the A-type cytoplasmic tail.
Mating between heterozygous (PcdhaΔA/+) mice resulted in homozygous, heterozygous, and WT mice at the expected Mendelian ratio. Homozygous PcdhaΔA/ΔA mice were fertile and appeared the same as WT mice at 4–8 weeks of age, but their body weight was below that of WT mice from 12 to 96 weeks of age (supplemental Fig. 3A, available at www.jneurosci.org as supplemental material), an effect that was also seen in homozygous PcdhaΔCR/ΔCR mice older than 72 weeks (supplemental Fig. 3B, available at www.jneurosci.org as supplemental material). In addition, by 36 weeks of age, PcdhaΔA/ΔA and PcdhaΔCR/ΔCR mice gradually developed lesions on their head, neck, and snout regions (supplemental Figs. 4A–D, 5A,B, available at www.jneurosci.org as supplemental material). At 96 weeks, approximately half of the PcdhaΔA/ΔA mice had some lesions on their bodies. These old, injured homozygous PcdhaΔA/ΔA and PcdhaΔCR/ΔCR mice groomed themselves more frequently than WT mice, leading to the injuries.
Loss of the Pcdha A-type, but not the B-type, cytoplasmic region causes abnormal serotonergic projections
Next, we examined the projections of the serotonergic fibers in the PcdhaΔA/ΔA and PcdhaΔB/ΔB mice, and compared them with WT and with the abnormalities found in the PcdhaΔCR/ΔCR mice. In the PcdhaΔA/ΔA mice, the distribution pattern of the serotonergic fibers in the hippocampus (Fig. B) was abnormal compared with WT mice (Fig. 7A), and quite similar to that of the PcdhaΔCR/ΔCR mice (Fig. 5B). A quantitative analysis showed that the densities of the serotonergic fibers of PcdhaΔA/ΔA mice were significantly higher in the stratum lacunosum-moleculare (170%) and lower in the dentate gyrus (41%) compared with WT mice (Fig. 7D). In contrast to the PcdhaΔA/ΔA mice, the densities of serotonergic fibers in the Pcdha+/ΔA and PcdhaΔB/ΔB mice were similar to those of WT mice (Fig. 7A–D, data not shown). Furthermore, the serotonergic projections of the PcdhaΔA/ΔA mice, but not those of the Pcdha+/ΔA or PcdhaΔB/ΔB mice, were essentially the same as for the PcdhaΔCR/ΔCR mice in the cerebral cortex, hippocampus, basal ganglia and thalamus. In addition, the abnormal projections in the PcdhaΔA/ΔA were not detectable within the first several postnatal days, as with the PcdhaΔCR/ΔCR mice. These data indicated that the Pcdha A-type splice variant, but not the B-type variant, is important for the normal innervation of target regions by serotonergic projections from the raphe nuclei, and for their even distribution.
Analysis of monoamine levels in the hippocampus of Pcdha gene-targeted mice
The amount of serotonin is higher in the hippocampus of the hypomorphic Pcdha A-type mutants (PcdhaΔAneo/ΔAneo and PcdhaΔBneo/ΔBneo) than in the PcdhaΔB/ΔB mouse (Fukuda et al., 2008). Therefore, we examined the serotonin levels in the hippocampus of adult PcdhaΔA/ΔA and PcdhaΔCR/ΔCR mice. In the hippocampus of 10-week-old mice, the amount of serotonin was significantly higher in the PcdhaΔA/ΔA (p < 0.05) and PcdhaΔCR/ΔCR mice (p < 0.001) than in WT mice, and the amount of 5-hydroxyindoleacetic acid (the main metabolite of serotonin) was significantly higher in the PcdhaΔA/ΔA mice (p < 0.01), although the amount of noradrenalin for all the genotypes was the same (Fig. 8A,B). These results demonstrated that the serotonin level in the hippocampus was strongly associated with the in vivo function of the Pcdha A-type protein.
Cortical barrel fields in the PcdhaΔCR/ΔCR mice
It has been shown that serotonin is a key neurotransmitter to form the cortical barrels, which are cellular aggregates in the somatosensory cortex and represent somatotopic organization for sensory inputs, especially inputs from vibrissae on the face (Woolsey and Van der Loos, 1970). Thus, we examined the cortical barrels to investigate the consequence of the altered serotonergic system in the PcdhaΔCR/ΔCR mice. However, we could not detect the structural abnormalities in the barrel fields of the PcdhaΔCR/ΔCR mice by either of SERT immunostaning or cytochrome oxidase histochemistry (supplemental Fig. 6A–D, available at www.jneurosci.org as supplemental material).
Discussion
Serotonergic neurons, like the other monoaminergic neurons, project their axons from the brain stem, including the raphe nuclei, to most regions of the CNS. However, the mechanism that controls the global projections of serotonergic neurons to their targets is largely unknown. Here we found that Pcdha transcripts were strongly expressed in the raphe nuclei from embryonic stages through adulthood, and therefore we examined the distribution of serotonergic projections from these nuclei in several mouse lines encoding mutant Pcdha proteins.
The deletion of the Pcdha-CR exons (PcdhaΔCR/ΔCR mice) led to abnormally distributed serotonergic fibers in many brain regions by P21. These abnormalities were also detected in a full knock-out mutant of the Pcdha, in which the Pcdha gene cluster is completely deleted (Okayama A, Hasegawa S, Hirabayashi T, Katori S, Yagi T, unpublished data). Early in postnatal life (before the formation of terminal arbors in the target regions), the distribution pattern of serotonergic fibers in the PcdhaΔCR/ΔCR mice was similar to that in WT mice. However, at P21, the distribution of serotonergic axons in PcdhaΔCR/ΔCR mice was substantially altered. That is, the axons approached their target regions normally, but they did not form the extensive axonal arbors seen in adult WT mice at the same age, when the serotonergic projections are almost complete.
Lidov and Molliver (1982) proposed that the ontogeny of the serotonergic axonal projections is divided into three periods: first, axon elongation (E13–E16); second, development of selective pathways (E15–E19); and third, terminal field development (E19–P21). Our results indicate that the Pcdha proteins may function during the final period, during terminal field development. The PcdhaΔCR/ΔCR mice showed low densities of innervating fibers in the central part of several target regions, such as the globus pallidus and substantia nigra, which could be explained by insufficient terminal arborization of the serotonergic fibers, which did penetrate the targets' periphery. Unlike the fiber termini, serotonergic axon bundles, such as the medial forebrain bundle, appeared normal in PcdhaΔCR/ΔCR mice (Fig. 4C,D). During the terminal field development, the formation of serotonergic terminal arborization is dependent on the maturation of other elements in the local neuronal circuitry (Lidov and Molliver, 1982), suggesting that the Pcdha proteins might be involved in the interactions that promote terminal field development.
Factors that regulate serotonergic axon outgrowth and terminal arborization have been suggested by studies on the ontogeny of serotonergic innervation. S-100β, a Ca2+-binding protein secreted from astroglia, functions as a growth factor in vitro by inducing serotonergic sprouting (Azmitia et al., 1990; Haring et al., 1993), but S-100β-null mice show normal serotonergic projections (Nishiyama et al., 2002). Brain-derived neurotrophic factor (BDNF) can induce serotonergic axonal growth in the adult cortex (Mamounas et al., 1995, 2000), and serotonergic projections are normal in younger BDNF+/− mice, but a progressive loss of serotonergic fibers is observed when they are 12–18 months old (Lyons et al., 1999). Thus, the secreted S-100β and BDNF proteins regulate serotonergic projections, and the loss of either may be compensated for by other extracellular proteins, at least early in development. The cytoplasmic protein GAP-43, a growth-associated protein, is strongly expressed in monoaminergic neurons (Bendotti et al., 1991; Wotherspoon et al., 1997), and is a regulator for serotonergic projections. GAP-43-null mice have abnormal serotonergic projections, but the abnormalities are different from those of our PcdhaΔCR/ΔCR mice. At P0, few serotonergic fibers in GAP-43-null mice have arrived at the hippocampus (Donovan et al., 2002), whereas in Pcdha mutants the fibers appear to arrive at the target almost normally. At P21, in the Pcdha mutants the amount of serotonergic axons arriving at the hippocampal region was normal, although their distribution within the hippocampal subregions was abnormal (Fig. 5F). In contrast, in GAP-43-null mice, the density of serotonergic axons arriving at the hippocampal region was lower, compared with WT mice (Donovan et al., 2002). Thus, in the regulation of serotonergic projections, GAP-43's function may be required in early developmental stages, and the roles of the Pcdha proteins may be significant only later in development.
We recently demonstrated that the OSNs of PcdhaΔCR/ΔCR mice project abnormally to the olfactory bulb (Hasegawa et al., 2008). In the olfactory bulb of PcdhaΔCR/ΔCR mice, axons expressing a single olfactory receptor (M71 or MOR23) do not coalesce into one glomerulus on each side of the olfactory bulb, but instead form multiple small glomeruli that persist even at P30 and P60. In WT mice, abnormal axonal projections to small multiple glomeruli are observed in the developing olfactory bulb; however, these supernumerary glomeruli are gradually eliminated during postnatal maturation. Therefore, the abnormality of the OSN projections in the PcdhaΔCR/ΔCR mice is consistent with the idea that Pcdha proteins function in the final maturation stage of axonal projections.
In the present study, we could not propose suitable models to explain the phenotype of serotonergic fibers in the PcdhaΔCR/ΔCR mice because the mechanism for how Pcdha proteins modify serotonergic axon outgrowth and terminal arborization is still unclear. This ignorance is considerably due to the lack of the information on the adhesion properties and subcellular localization of Pcdha proteins. Although it has been suggested that Pcdha proteins interact with β1-integrin in a trans-heterophilic manner (Mutoh et al., 2004), trans-homophilic adhesion of Pcdha proteins could not be detected (Morishita et al., 2006). Furthermore, the subcellular localization of Pcdha proteins in serotonergic neurons and their targets could not be determined. During the formation of serotonergic terminal arbors, most of the neurons in the brain express detectable Pcdha transcripts. Our immunohistochemical examination with the Pcdha antibodies demonstrate intense immunoreactivity in the serotonergic somata but fail to determine the subcellular localization of the Pcdha proteins in the target regions of the serotonergic axons; Pcdha immunoreactivity was rather homogeneously distributed in the neuropil (data not shown, Hasegawa et al., 2008). To clarify the subcellular localization of Pcdha proteins, further studies including immunoelectron microscopy will be necessary.
Here we demonstrated that the A-type cytoplasmic tail of Pcdha proteins is important for the normal distribution of serotonergic projections. The A-type cytoplasmic tail of Pcdhas is reported to associate with neurofilament M (Triana-Baltzer and Blank, 2006). Furthermore, Pcdha proteins are subject to matrix metalloprotease cleavage followed by presenilin-dependent intramembrane proteolysis, and the cleaved portion of the A-type cytoplasmic region translocates into the nucleus from the plasma membrane (Bonn et al., 2007). Therefore, the A-type cytoplasmic region may play a crucial role in signal transduction.
Although the signals transduced by the Pcdha proteins are not known, some possibilities have been suggested by recent findings. For example, a similar phenotype of abnormal, clumped axons was reported for the retinal axons of Dscam (Down syndrome cell adhesion molecule) mutant mice (Fuerst et al., 2008). Mammalian DSCAM, an Ig superfamily member, shows homophilic binding (Agarwala et al., 2000); it promotes self-avoidance (isoneuronal) for arborizing processes and inhibits the fasciculation of processes from different neurons (heteroneuronal) (Fuerst et al., 2008). This similarity raises the possibility that the Pcdha protein might function in the self-avoidance of serotonergic neurons. A-type cytoplasmic tail may transduce repulsive signals in the serotonergic neurons. The defect of self-avoidance may directly influence serotonergic axon outgrowth and terminal arborization. Alternatively, the insufficient self-avoidance may affect the configuration of recurrent collaterals of serotonergic neurons which regulate the activity of these neurons, and then indirectly change the terminal arbors by activity-dependent mechanisms.
Here we demonstrated that Pcdha molecules play significant roles in the establishment of normal serotonergic projections in every brain region we studied. We also found that in PcdhaΔCR/ΔCR and PcdhaΔA/ΔA mice, the serotonin levels of the hippocampus were significantly increased, compared with WT. Previously, we reported that hypomorphic Pcdha A-type mutant mice (PcdhaΔBneo/ΔBneo), in which Pcdha B-type transcripts are not detected and the expression level of Pcdha A-type transcripts is reduced, show an increased amount of serotonin in the hippocampus, and enhanced contextual fear conditioning and abnormal spatial learning (Fukuda et al., 2008). Together, these data are consistent with the idea that abnormal levels of serotonin in the hippocampus result from mutations of the Pcdha cytoplasmic tail, and that the altered serotonin levels could affect behavior.
The human protocadherin gene clusters (Pcdha, Pcdhb, and Pcdhg) are located on chromosome 5q31 (Wu and Maniatis, 1999). This locus is associated with BD (Lewis et al., 2003; Hong et al., 2004; Herzberg et al., 2006; Kerner et al., 2007). A recent study demonstrated a significant increase in homozygosity of the minor allele, which contains a single-nucleotide polymorphism in a putative enhancer for the Pcdha gene, in patients with BD (Pedrosa et al., 2008).
Whether or not the association with BD holds up, abnormal serotonergic innervation is implicated in a number of neuropsychiatric disorders, including depression, anxiety, schizophrenia, and autism (Baumgarten and Grozdanovic, 1995; Hen, 1996; Mann, 1998). Here, our observation that Pcdhas contributed to appropriate serotonergic projections in much if not all of the brain, suggests that Pcdhas could also be involved with the pathogenic mechanisms of a number of neuropsychiatric disorders, via their regulation of serotonergic projections.
Footnotes
This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan (T.Y.), a Grant-in-Aid for Scientific Research (S) (T.Y.), a Grant-in-Aid for Scientific Research on Priority Areas—Advanced Brain Science Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (S.H.), and a grant from the Japan Foundation for Neuroscience and Mental Health (S.H.). We thank the members of the KOKORO Biology Laboratory for assistance and discussions, and M. Sanbo, N. Yamauchi, H. Masuda, and E. Naruto for technical assistance. We are grateful to Jun-ichi Miyazaki (Osaka University, Japan) for the CAG-Cre transgenic mice, and Masahiko Watanabe (Hokkaido University, Japan) for the anti-SERT antibody.
References
- Agarwala KL, Nakamura S, Tsutsumi Y, Yamakawa K. Down syndrome cell adhesion molecule DSCAM mediates homophilic intercellular adhesion. Brain Res Mol Brain Res. 2000;79:118–126. doi: 10.1016/s0169-328x(00)00108-x. [DOI] [PubMed] [Google Scholar]
- Azmitia EC, Dolan K, Whitaker-Azmitia PM. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res. 1990;516:354–356. doi: 10.1016/0006-8993(90)90942-5. [DOI] [PubMed] [Google Scholar]
- Baumgarten HG, Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry. 1995;28(Suppl 2):73–79. doi: 10.1055/s-2007-979623. [DOI] [PubMed] [Google Scholar]
- Bendotti C, Servadio A, Samanin R. Distribution of GAP-43 mRNA in the brain stem of adult rats as evidenced by in situ hybridization: localization within monoaminergic neurons. J Neurosci. 1991;11:600–607. doi: 10.1523/JNEUROSCI.11-03-00600.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonn S, Seeburg PH, Schwarz MK. Combinatorial expression of alpha- and gamma-protocadherins alters their presenilin-dependent processing. Mol Cell Biol. 2007;27:4121–4132. doi: 10.1128/MCB.01708-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carroll P, Gayet O, Feuillet C, Kallenbach S, de Bovis B, Dudley K, Alonso S. Juxtaposition of CNR protocadherins and reelin expression in the developing spinal cord. Mol Cell Neurosci. 2001;17:611–623. doi: 10.1006/mcne.2001.0966. [DOI] [PubMed] [Google Scholar]
- Donovan SL, Mamounas LA, Andrews AM, Blue ME, McCasland JS. GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J Neurosci. 2002;22:3543–3552. doi: 10.1523/JNEUROSCI.22-09-03543.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Esumi S, Kakazu N, Taguchi Y, Hirayama T, Sasaki A, Hirabayashi T, Koide T, Kitsukawa T, Hamada S, Yagi T. Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons. Nat Genet. 2005;37:171–176. doi: 10.1038/ng1500. [DOI] [PubMed] [Google Scholar]
- Fuerst PG, Koizumi A, Masland RH, Burgess RW. Neurite arborization and mosaic spacing in the mouse retina require DSCAM. Nature. 2008;451:470–474. doi: 10.1038/nature06514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fukuda E, Hamada S, Hasegawa S, Katori S, Sanbo M, Miyakawa T, Yamamoto T, Yamamoto H, Hirabayashi T, Yagi T. Down-regulation of protocadherin-alpha A isoforms in mice changes contextual fear conditioning and spatial working memory. Eur J Neurosci. 2008;28:1362–1376. doi: 10.1111/j.1460-9568.2008.06428.x. [DOI] [PubMed] [Google Scholar]
- Haring JH, Hagan A, Olson J, Rodgers B. Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistry. Brain Res. 1993;631:119–123. doi: 10.1016/0006-8993(93)91195-x. [DOI] [PubMed] [Google Scholar]
- Hasegawa S, Hamada S, Kumode Y, Esumi S, Katori S, Fukuda E, Uchiyama Y, Hirabayashi T, Mombaerts P, Yagi T. The protocadherin-alpha family is involved in axonal coalescence of olfactory sensory neurons into glomeruli of the olfactory bulb in mouse. Mol Cell Neurosci. 2008;38:66–79. doi: 10.1016/j.mcn.2008.01.016. [DOI] [PubMed] [Google Scholar]
- Hen R. Mean genes. Neuron. 1996;16:17–21. doi: 10.1016/s0896-6273(00)80019-7. [DOI] [PubMed] [Google Scholar]
- Herzberg I, Jasinska A, García J, Jawaheer D, Service S, Kremeyer B, Duque C, Parra MV, Vega J, Ortiz D, Carvajal L, Polanco G, Restrepo GJ, López C, Palacio C, Levinson M, Aldana I, Mathews C, Davanzo P, Molina J, et al. Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Hum Mol Genet. 2006;15:3146–3153. doi: 10.1093/hmg/ddl254. [DOI] [PubMed] [Google Scholar]
- Hong KS, McInnes LA, Service SK, Song T, Lucas J, Silva S, Fournier E, León P, Molina J, Reus VI, Sandkuijl LA, Freimer NB. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am J Med Genet B Neuropsychiatr Genet. 2004;125B:83–86. doi: 10.1002/ajmg.b.20091. [DOI] [PubMed] [Google Scholar]
- Junghans D, Heidenreich M, Hack I, Taylor V, Frotscher M, Kemler R. Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system. Eur J Neurosci. 2008;27:559–571. doi: 10.1111/j.1460-9568.2008.06052.x. [DOI] [PubMed] [Google Scholar]
- Kaneko R, Kato H, Kawamura Y, Esumi S, Hirayama T, Hirabayashi T, Yagi T. Allelic gene regulation of Pcdh-alpha and Pcdh-gamma clusters involving both monoallelic and biallelic expression in single Purkinje cells. J Biol Chem. 2006;281:30551–30560. doi: 10.1074/jbc.M605677200. [DOI] [PubMed] [Google Scholar]
- Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, Takeda J, Tabayashi K, Miyazaki J. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 2000;470:263–268. doi: 10.1016/s0014-5793(00)01338-7. [DOI] [PubMed] [Google Scholar]
- Kerner B, Brugman DL, Freimer NB. Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:74–78. doi: 10.1002/ajmg.b.30402. [DOI] [PubMed] [Google Scholar]
- Kohmura N, Senzaki K, Hamada S, Kai N, Yasuda R, Watanabe M, Ishii H, Yasuda M, Mishina M, Yagi T. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron. 1998;20:1137–1151. doi: 10.1016/s0896-6273(00)80495-x. [DOI] [PubMed] [Google Scholar]
- Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet. 2003;73:34–48. doi: 10.1086/376549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lidov HG, Molliver ME. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull. 1982;8:389–430. doi: 10.1016/0361-9230(82)90077-6. [DOI] [PubMed] [Google Scholar]
- Lidov HG, Grzanna R, Molliver ME. The serotonin innervation of the cerebral cortex in the rat—an immunohistochemical analysis. Neuroscience. 1980;5:207–227. doi: 10.1016/0306-4522(80)90099-8. [DOI] [PubMed] [Google Scholar]
- Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A. 1999;96:15239–15244. doi: 10.1073/pnas.96.26.15239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 1995;15:7929–7939. doi: 10.1523/JNEUROSCI.15-12-07929.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci. 2000;20:771–782. doi: 10.1523/JNEUROSCI.20-02-00771.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mann JJ. The role of in vivo neurotransmitter system imaging studies in understanding major depression. Biol Psychiatry. 1998;44:1077–1078. doi: 10.1016/s0006-3223(98)00299-6. [DOI] [PubMed] [Google Scholar]
- Morishita H, Murata Y, Esumi S, Hamada S, Yagi T. CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. Neuroreport. 2004;15:2595–2599. doi: 10.1097/00001756-200412030-00007. [DOI] [PubMed] [Google Scholar]
- Morishita H, Umitsu M, Murata Y, Shibata N, Udaka K, Higuchi Y, Akutsu H, Yamaguchi T, Yagi T, Ikegami T. Structure of the cadherin-related neuronal receptor/protocadherin-alpha first extracellular cadherin domain reveals diversity across cadherin families. J Biol Chem. 2006;281:33650–33663. doi: 10.1074/jbc.M603298200. [DOI] [PubMed] [Google Scholar]
- Murata Y, Hamada S, Morishita H, Mutoh T, Yagi T. Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. J Biol Chem. 2004;279:49508–49516. doi: 10.1074/jbc.M408771200. [DOI] [PubMed] [Google Scholar]
- Mutoh T, Hamada S, Senzaki K, Murata Y, Yagi T. Cadherin-related neuronal receptor 1 (CNR1) has cell adhesion activity with beta1 integrin mediated through the RGD site of CNR1. Exp Cell Res. 2004;294:494–508. doi: 10.1016/j.yexcr.2003.11.019. [DOI] [PubMed] [Google Scholar]
- Nishiyama H, Takemura M, Takeda T, Itohara S. Normal development of serotonergic neurons in mice lacking S100B. Neurosci Lett. 2002;321:49–52. doi: 10.1016/s0304-3940(01)02549-6. [DOI] [PubMed] [Google Scholar]
- Obata S, Sago H, Mori N, Rochelle JM, Seldin MF, Davidson M, St John T, Taketani S, Suzuki ST. Protocadherin Pcdh2 shows properties similar to, but distinct from, those of classical cadherins. J Cell Sci. 1995;108:3765–3773. doi: 10.1242/jcs.108.12.3765. [DOI] [PubMed] [Google Scholar]
- Pedrosa E, Stefanescu R, Margolis B, Petruolo O, Lo Y, Nolan K, Novak T, Stopkova P, Lachman HM. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia. Schizophr Res. 2008;102:210–219. doi: 10.1016/j.schres.2008.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phillips GR, Tanaka H, Frank M, Elste A, Fidler L, Benson DL, Colman DR. Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons. J Neurosci. 2003;23:5096–5104. doi: 10.1523/JNEUROSCI.23-12-05096.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaeren-Wiemers N, Gerfin-Moser A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry. 1993;100:431–440. doi: 10.1007/BF00267823. [DOI] [PubMed] [Google Scholar]
- Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, Lichtermann D, Ertl MA, Maier W, Wildenauer DB. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry. 1997;2:156–160. doi: 10.1038/sj.mp.4000263. [DOI] [PubMed] [Google Scholar]
- Sugino H, Hamada S, Yasuda R, Tuji A, Matsuda Y, Fujita M, Yagi T. Genomic organization of the family of CNR cadherin genes in mice and humans. Genomics. 2000;63:75–87. doi: 10.1006/geno.1999.6066. [DOI] [PubMed] [Google Scholar]
- Triana-Baltzer GB, Blank M. Cytoplasmic domain of protocadherin-alpha enhances homophilic interactions and recognizes cytoskeletal elements. J Neurobiol. 2006;66:393–407. doi: 10.1002/neu.20228. [DOI] [PubMed] [Google Scholar]
- Woolsey TA, Van der Loos H. The structural organization of layer IV in the somatosensory region (SI) of mouse cerebral cortex. The description of a cortical field composed of discrete cytoarchitectonic units. Brain Res. 1970;17:205–242. doi: 10.1016/0006-8993(70)90079-x. [DOI] [PubMed] [Google Scholar]
- Wotherspoon G, López-Costa JJ, Michael GJ, Priestley JV. Constitutive expression of calmodulin-binding phosphoprotein GAP-43 in rat serotonergic and noradrenergic cell groups which project to the spinal cord. Neurochem Res. 1997;22:985–993. doi: 10.1023/a:1022474826040. [DOI] [PubMed] [Google Scholar]
- Wu Q, Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 1999;97:779–790. doi: 10.1016/s0092-8674(00)80789-8. [DOI] [PubMed] [Google Scholar]
- Wu Q, Zhang T, Cheng JF, Kim Y, Grimwood J, Schmutz J, Dickson M, Noonan JP, Zhang MQ, Myers RM, Maniatis T. Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. Genome Res. 2001;11:389–404. doi: 10.1101/gr.167301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yagi T. Clustered protocadherin family. Dev Growth Differ. 2008;50(Suppl 1):S131–S140. doi: 10.1111/j.1440-169X.2008.00991.x. [DOI] [PubMed] [Google Scholar]